The company's purpose is to conduct research, development and commercialization of pharmaceutical products and services in its own name and on behalf of third parties, including the conduct of related studies and productions up to market readiness. The company also aims to acquire, manage and exploit participations in companies of all kinds at home and abroad, including their financing. The company can acquire, hold and sell intellectual property rights and licenses of all kinds. The company can enter into all commercial, contractual and financial transactions that are suitable to promote the purpose of the company or that are directly or indirectly related to it. Furthermore, the company can establish subsidiaries and branches at home and abroad and participate in or merge with other companies. The company can also carry out all commercial, financial and other activities that are directly or indirectly related to the purpose of the company. The company can grant direct or indirect financing to third parties or companies in which it is directly or indirectly involved, as well as to direct or indirect shareholders or companies in which such parties are directly or indirectly involved, whether by means of loans and/or other financing, with or without consideration. The company can provide security of any kind for its own liabilities or the liabilities of the aforementioned persons, including by means of pledges, assignments, fiduciary transfers, guarantees of any kind or by means of offset obligations, with or without consideration, even if such financing, security or guarantees are in the exclusive interest of third parties or companies in which it is directly or indirectly involved, or of direct or indirect shareholders or companies in which such parties are directly or indirectly involved.